{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:07:31Z","timestamp":1775556451566,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jaip.2026.01.031","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:35:06Z","timestamp":1775554506000},"page":"1001-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to \u201cDupilumab-induced blood eosinophilia: Why temporal patterns matter\u201d"],"prefix":"10.1016","volume":"14","author":[{"given":"Eugenio","family":"De Corso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.01.031_bib1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jaip.2026.01.030","article-title":"Dupilumab-induced blood eosinophilia: why temporal patterns matter","volume":"14","author":"Poto","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.031_bib2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jaip.2025.10.032","article-title":"Dupilumab-induced blood eosinophilia in patients with chronic rhinosinusitis with nasal polyps: temporal trends and correlation with adverse events","volume":"14","author":"De Corso","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.031_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/17476348.2025.2604322","article-title":"When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications","author":"Caminati","year":"2026","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaip.2026.01.031_bib4","article-title":"Lung function impairment and eosinophilia in patients with eosinophilic chronic rhinosinusitis","volume":"4","author":"Sonoda","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2026.01.031_bib5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/jpm14091014","article-title":"Sinonasal outcomes obtained after 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and CRSwNP: a \"real-life\" observational study","volume":"14","author":"De Corso","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaip.2026.01.031_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(25)00401-1","article-title":"EVEREST and the eosinophil paradox\u2014authors' reply","volume":"13","author":"De Corso","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.01.031_bib7","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00405-023-08417-8","article-title":"Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study","volume":"281","author":"De Corso","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2026.01.031_bib8","first-page":"768","article-title":"Clinical management of dupilumab-induced blood eosinophilia in CRSwNP: a practical algorithm","volume":"63","author":"De Corso","year":"2025","journal-title":"Rhinology"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:36:44Z","timestamp":1775554604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213219826000826"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.031","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply to \u201cDupilumab-induced blood eosinophilia: Why temporal patterns matter\u201d","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.030","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}